Serada (Depomed) filed at FDA for treatment of Hot Flashes - 02-Aug-2012

Depomed Inc., has submitted a New Drug Application (NDA) for Serada (gabapentin GR) to the FDA. Serada is a proprietary extended release formulation of gabapentin in development for the treatment of Menopausal Hot Flashes.

Related News

Related Women's Health and Obs/Gyn Information

Women's Health and Obs/Gyn Clinical Guidelines

Antenatal and postnatal mental health

NICE

Antenatal care: Routine care for the healthy pregnant woman

NICE

Women's Health and Obs/Gyn Clinical Trials

Bone Healing in Healthy and Post-menopausal Osteoporotic Women

Clinicaltrials.gov 26 March 2013

TMMR Register Study (TMMR-RS)

Clinicaltrials.gov 19 March 2013

Women's Health and Obs/Gyn Medical Journal Abstracts

Efficacy and safety of intraoperative intravenous methadone during general anaesthesia for caesarean delivery: a retrospective case-control study

International Journal of Obstetric Anesthesia 10 December 2012

Insertion of an intrathecal catheter following accidental dural puncture: a meta-analysis

International Journal of Obstetric Anesthesia 06 December 2012

Women's Health and Obs/Gyn Medical Apps

Obstetics and Gynecology On Call

£0.69

Women's Health

Free

Related Women's Health and Obs/Gyn Drugs

Back to top

Latest News

10 May 2015
22 May 2013
22 May 2013